Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0008023 | transcription elongation factor complex | 3 | 12 |
GO:0016593 | Cdc73/Paf1 complex | 4 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0140513 | nuclear protein-containing complex | 2 | 12 |
GO:0005634 | nucleus | 5 | 1 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8IMF9
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006354 | DNA-templated transcription elongation | 6 | 12 |
GO:0006368 | transcription elongation by RNA polymerase II | 7 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009058 | biosynthetic process | 2 | 12 |
GO:0009059 | macromolecule biosynthetic process | 4 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0016570 | histone modification | 5 | 12 |
GO:0018130 | heterocycle biosynthetic process | 4 | 12 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0032774 | RNA biosynthetic process | 5 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 12 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044249 | cellular biosynthetic process | 3 | 12 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:1901576 | organic substance biosynthetic process | 3 | 12 |
GO:0006355 | regulation of DNA-templated transcription | 6 | 1 |
GO:0006357 | regulation of transcription by RNA polymerase II | 7 | 1 |
GO:0009889 | regulation of biosynthetic process | 4 | 1 |
GO:0009891 | positive regulation of biosynthetic process | 5 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 6 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031325 | positive regulation of cellular metabolic process | 5 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
GO:0031328 | positive regulation of cellular biosynthetic process | 6 | 1 |
GO:0032784 | regulation of DNA-templated transcription elongation | 7 | 1 |
GO:0032786 | positive regulation of DNA-templated transcription, elongation | 8 | 1 |
GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 9 | 1 |
GO:0034243 | regulation of transcription elongation by RNA polymerase II | 8 | 1 |
GO:0045893 | positive regulation of DNA-templated transcription | 7 | 1 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 8 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048522 | positive regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051254 | positive regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:1902680 | positive regulation of RNA biosynthetic process | 7 | 1 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 1 |
GO:1903508 | positive regulation of nucleic acid-templated transcription | 8 | 1 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000993 | RNA polymerase II complex binding | 5 | 1 |
GO:0001098 | basal transcription machinery binding | 3 | 1 |
GO:0001099 | basal RNA polymerase II transcription machinery binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0019899 | enzyme binding | 3 | 1 |
GO:0043175 | RNA polymerase core enzyme binding | 5 | 1 |
GO:0045309 | protein phosphorylated amino acid binding | 4 | 1 |
GO:0050815 | phosphoserine residue binding | 5 | 1 |
GO:0051219 | phosphoprotein binding | 3 | 1 |
GO:0070063 | RNA polymerase binding | 4 | 1 |
GO:0099122 | RNA polymerase II C-terminal domain binding | 6 | 1 |
GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 430 | 434 | PF00656 | 0.745 |
CLV_C14_Caspase3-7 | 439 | 443 | PF00656 | 0.671 |
CLV_NRD_NRD_1 | 290 | 292 | PF00675 | 0.385 |
CLV_NRD_NRD_1 | 317 | 319 | PF00675 | 0.373 |
CLV_NRD_NRD_1 | 341 | 343 | PF00675 | 0.266 |
CLV_NRD_NRD_1 | 382 | 384 | PF00675 | 0.373 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.681 |
CLV_PCSK_KEX2_1 | 290 | 292 | PF00082 | 0.360 |
CLV_PCSK_KEX2_1 | 340 | 342 | PF00082 | 0.303 |
CLV_PCSK_KEX2_1 | 382 | 384 | PF00082 | 0.375 |
CLV_PCSK_KEX2_1 | 398 | 400 | PF00082 | 0.549 |
CLV_PCSK_PC1ET2_1 | 149 | 151 | PF00082 | 0.681 |
CLV_PCSK_PC1ET2_1 | 340 | 342 | PF00082 | 0.331 |
CLV_PCSK_PC1ET2_1 | 398 | 400 | PF00082 | 0.687 |
CLV_PCSK_PC7_1 | 145 | 151 | PF00082 | 0.546 |
CLV_PCSK_PC7_1 | 337 | 343 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.486 |
CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.693 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 270 | 274 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 337 | 341 | PF00082 | 0.437 |
CLV_PCSK_SKI1_1 | 347 | 351 | PF00082 | 0.284 |
CLV_PCSK_SKI1_1 | 383 | 387 | PF00082 | 0.316 |
CLV_PCSK_SKI1_1 | 467 | 471 | PF00082 | 0.658 |
CLV_PCSK_SKI1_1 | 486 | 490 | PF00082 | 0.446 |
CLV_PCSK_SKI1_1 | 70 | 74 | PF00082 | 0.427 |
DEG_APCC_DBOX_1 | 485 | 493 | PF00400 | 0.446 |
DEG_APCC_DBOX_1 | 69 | 77 | PF00400 | 0.466 |
DOC_CKS1_1 | 194 | 199 | PF01111 | 0.411 |
DOC_CYCLIN_yCln2_LP_2 | 160 | 166 | PF00134 | 0.524 |
DOC_MAPK_gen_1 | 101 | 111 | PF00069 | 0.579 |
DOC_MAPK_gen_1 | 340 | 351 | PF00069 | 0.411 |
DOC_MAPK_gen_1 | 398 | 408 | PF00069 | 0.614 |
DOC_PP1_RVXF_1 | 213 | 220 | PF00149 | 0.266 |
DOC_PP2B_LxvP_1 | 160 | 163 | PF13499 | 0.525 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.507 |
DOC_USP7_MATH_1 | 305 | 309 | PF00917 | 0.226 |
DOC_USP7_MATH_1 | 484 | 488 | PF00917 | 0.431 |
DOC_USP7_MATH_1 | 498 | 502 | PF00917 | 0.364 |
DOC_USP7_UBL2_3 | 340 | 344 | PF12436 | 0.331 |
DOC_WW_Pin1_4 | 152 | 157 | PF00397 | 0.484 |
DOC_WW_Pin1_4 | 193 | 198 | PF00397 | 0.475 |
DOC_WW_Pin1_4 | 511 | 516 | PF00397 | 0.552 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.708 |
LIG_14-3-3_CanoR_1 | 169 | 173 | PF00244 | 0.396 |
LIG_14-3-3_CanoR_1 | 202 | 210 | PF00244 | 0.317 |
LIG_14-3-3_CanoR_1 | 218 | 226 | PF00244 | 0.274 |
LIG_14-3-3_CanoR_1 | 347 | 352 | PF00244 | 0.301 |
LIG_14-3-3_CanoR_1 | 93 | 99 | PF00244 | 0.470 |
LIG_AP2alpha_2 | 421 | 423 | PF02296 | 0.714 |
LIG_APCC_ABBA_1 | 109 | 114 | PF00400 | 0.560 |
LIG_APCC_ABBA_1 | 86 | 91 | PF00400 | 0.614 |
LIG_APCC_ABBAyCdc20_2 | 169 | 175 | PF00400 | 0.368 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.555 |
LIG_BRCT_BRCA1_1 | 188 | 192 | PF00533 | 0.459 |
LIG_BRCT_BRCA1_1 | 419 | 423 | PF00533 | 0.514 |
LIG_FHA_1 | 196 | 202 | PF00498 | 0.275 |
LIG_FHA_1 | 223 | 229 | PF00498 | 0.274 |
LIG_FHA_1 | 240 | 246 | PF00498 | 0.407 |
LIG_FHA_1 | 247 | 253 | PF00498 | 0.414 |
LIG_FHA_1 | 271 | 277 | PF00498 | 0.442 |
LIG_FHA_1 | 537 | 543 | PF00498 | 0.475 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.529 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.708 |
LIG_FHA_2 | 134 | 140 | PF00498 | 0.660 |
LIG_FHA_2 | 17 | 23 | PF00498 | 0.634 |
LIG_FHA_2 | 264 | 270 | PF00498 | 0.309 |
LIG_FHA_2 | 348 | 354 | PF00498 | 0.281 |
LIG_FHA_2 | 512 | 518 | PF00498 | 0.546 |
LIG_GBD_Chelix_1 | 481 | 489 | PF00786 | 0.508 |
LIG_LIR_Apic_2 | 313 | 317 | PF02991 | 0.375 |
LIG_LIR_Gen_1 | 497 | 506 | PF02991 | 0.533 |
LIG_LIR_Gen_1 | 507 | 515 | PF02991 | 0.579 |
LIG_LIR_Nem_3 | 189 | 195 | PF02991 | 0.543 |
LIG_LIR_Nem_3 | 476 | 481 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 497 | 502 | PF02991 | 0.534 |
LIG_LIR_Nem_3 | 505 | 511 | PF02991 | 0.549 |
LIG_NRBOX | 484 | 490 | PF00104 | 0.435 |
LIG_Pex14_2 | 47 | 51 | PF04695 | 0.502 |
LIG_SH2_CRK | 478 | 482 | PF00017 | 0.391 |
LIG_SH2_SRC | 112 | 115 | PF00017 | 0.547 |
LIG_SH2_SRC | 186 | 189 | PF00017 | 0.463 |
LIG_SH2_SRC | 304 | 307 | PF00017 | 0.232 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.571 |
LIG_SH2_STAT5 | 186 | 189 | PF00017 | 0.504 |
LIG_SH2_STAT5 | 195 | 198 | PF00017 | 0.351 |
LIG_SH3_3 | 161 | 167 | PF00018 | 0.523 |
LIG_SH3_3 | 175 | 181 | PF00018 | 0.351 |
LIG_SUMO_SIM_anti_2 | 231 | 238 | PF11976 | 0.469 |
LIG_TRAF2_1 | 237 | 240 | PF00917 | 0.393 |
LIG_WRC_WIRS_1 | 441 | 446 | PF05994 | 0.526 |
MOD_CK1_1 | 211 | 217 | PF00069 | 0.360 |
MOD_CK1_1 | 220 | 226 | PF00069 | 0.273 |
MOD_CK1_1 | 471 | 477 | PF00069 | 0.595 |
MOD_CK2_1 | 133 | 139 | PF00069 | 0.644 |
MOD_CK2_1 | 263 | 269 | PF00069 | 0.472 |
MOD_CK2_1 | 319 | 325 | PF00069 | 0.334 |
MOD_CK2_1 | 347 | 353 | PF00069 | 0.283 |
MOD_DYRK1A_RPxSP_1 | 152 | 156 | PF00069 | 0.475 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.627 |
MOD_GlcNHglycan | 368 | 371 | PF01048 | 0.325 |
MOD_GlcNHglycan | 413 | 416 | PF01048 | 0.715 |
MOD_GlcNHglycan | 550 | 553 | PF01048 | 0.423 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.589 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.532 |
MOD_GSK3_1 | 231 | 238 | PF00069 | 0.294 |
MOD_GSK3_1 | 436 | 443 | PF00069 | 0.704 |
MOD_GSK3_1 | 498 | 505 | PF00069 | 0.451 |
MOD_GSK3_1 | 507 | 514 | PF00069 | 0.460 |
MOD_N-GLC_1 | 511 | 516 | PF02516 | 0.610 |
MOD_NEK2_1 | 137 | 142 | PF00069 | 0.519 |
MOD_NEK2_1 | 201 | 206 | PF00069 | 0.303 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.642 |
MOD_NEK2_1 | 66 | 71 | PF00069 | 0.433 |
MOD_NEK2_2 | 222 | 227 | PF00069 | 0.266 |
MOD_OFUCOSY | 179 | 184 | PF10250 | 0.565 |
MOD_PIKK_1 | 235 | 241 | PF00454 | 0.362 |
MOD_PIKK_1 | 25 | 31 | PF00454 | 0.728 |
MOD_PIKK_1 | 536 | 542 | PF00454 | 0.598 |
MOD_PK_1 | 319 | 325 | PF00069 | 0.287 |
MOD_PKA_2 | 168 | 174 | PF00069 | 0.432 |
MOD_PKA_2 | 201 | 207 | PF00069 | 0.354 |
MOD_PKA_2 | 217 | 223 | PF00069 | 0.287 |
MOD_PKA_2 | 92 | 98 | PF00069 | 0.475 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.539 |
MOD_Plk_1 | 239 | 245 | PF00069 | 0.423 |
MOD_Plk_1 | 305 | 311 | PF00069 | 0.403 |
MOD_Plk_1 | 39 | 45 | PF00069 | 0.588 |
MOD_Plk_2-3 | 278 | 284 | PF00069 | 0.331 |
MOD_Plk_2-3 | 429 | 435 | PF00069 | 0.642 |
MOD_Plk_2-3 | 436 | 442 | PF00069 | 0.579 |
MOD_Plk_4 | 154 | 160 | PF00069 | 0.528 |
MOD_Plk_4 | 231 | 237 | PF00069 | 0.381 |
MOD_Plk_4 | 504 | 510 | PF00069 | 0.490 |
MOD_ProDKin_1 | 152 | 158 | PF00069 | 0.472 |
MOD_ProDKin_1 | 193 | 199 | PF00069 | 0.391 |
MOD_ProDKin_1 | 511 | 517 | PF00069 | 0.554 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.707 |
MOD_SUMO_for_1 | 469 | 472 | PF00179 | 0.619 |
MOD_SUMO_for_1 | 542 | 545 | PF00179 | 0.521 |
TRG_DiLeu_BaEn_2 | 187 | 193 | PF01217 | 0.569 |
TRG_ENDOCYTIC_2 | 478 | 481 | PF00928 | 0.398 |
TRG_ER_diArg_1 | 290 | 293 | PF00400 | 0.385 |
TRG_ER_diArg_1 | 341 | 343 | PF00400 | 0.346 |
TRG_ER_diArg_1 | 381 | 383 | PF00400 | 0.367 |
TRG_ER_diArg_1 | 399 | 402 | PF00400 | 0.496 |
TRG_NLS_Bipartite_1 | 382 | 402 | PF00514 | 0.618 |
TRG_NLS_MonoExtC_3 | 339 | 344 | PF00514 | 0.428 |
TRG_NLS_MonoExtC_3 | 397 | 403 | PF00514 | 0.687 |
TRG_NLS_MonoExtN_4 | 316 | 322 | PF00514 | 0.411 |
TRG_NLS_MonoExtN_4 | 337 | 344 | PF00514 | 0.287 |
TRG_NLS_MonoExtN_4 | 395 | 402 | PF00514 | 0.683 |
TRG_Pf-PMV_PEXEL_1 | 321 | 325 | PF00026 | 0.411 |
TRG_Pf-PMV_PEXEL_1 | 341 | 345 | PF00026 | 0.411 |
TRG_Pf-PMV_PEXEL_1 | 486 | 491 | PF00026 | 0.541 |
TRG_Pf-PMV_PEXEL_1 | 525 | 529 | PF00026 | 0.551 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IMF7 | Leptomonas seymouri | 65% | 97% |
A0A0S4JFB0 | Bodo saltans | 27% | 85% |
A0A1X0P5N0 | Trypanosomatidae | 38% | 92% |
A0A3R7P349 | Trypanosoma rangeli | 36% | 96% |
A4HMV2 | Leishmania braziliensis | 84% | 100% |
A4IBH3 | Leishmania infantum | 99% | 100% |
C9ZZ69 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 96% |
E9AFA9 | Leishmania major | 95% | 100% |
E9B6G4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
V5BD17 | Trypanosoma cruzi | 38% | 92% |